doLoopTech Revenue and Competitors
Estimated Revenue & Valuation
- doLoopTech's estimated annual revenue is currently $210k per year.
- doLoopTech's estimated revenue per employee is $35,000
Employee Data
- doLoopTech has 6 Employees.
- doLoopTech grew their employee count by -60% last year.
doLoopTech's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
doLoopTech Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.4M | 10 | -23% | N/A | N/A |
#2 | $18.6M | 241 | -15% | N/A | N/A |
#3 | $6.7M | 95 | -7% | N/A | N/A |
#4 | $261.9M | 2672 | 9% | N/A | N/A |
#5 | $13.4M | 174 | 5% | N/A | N/A |
#6 | $1.4M | 29 | -12% | N/A | N/A |
#7 | $59.5M | 680 | 7% | N/A | N/A |
#8 | $9M | 128 | -2% | $28M | N/A |
#9 | $81.6M | 833 | 91% | N/A | N/A |
#10 | $53.5M | 611 | 5% | N/A | N/A |
What Is doLoopTech?
doLoop Technologies India Pvt. Ltd. was incorporated in 2014 as a software technology company with the vision to accelerate the clinical trial drug development process by providing automated medical document intelligence software solutions to the life sciences industry. As the name “doLoop†itself shows, our company is deeply rooted with the core concepts of computer science. Analytics has always been at the core of life sciences industry. The emphasis is on, how fast and efficient we can go from Patient-to-PValue. Our new age medical document intelligence clinical solutions and technology automations make it possible to achieve greater and much faster results than ever before. visit www.dolooptech.com for more details.
keywords:N/AN/A
Total Funding
6
Number of Employees
$210k
Revenue (est)
-60%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.2M | 6 | N/A | N/A |
#2 | $0.2M | 6 | N/A | N/A |
#3 | $0.2M | 6 | N/A | N/A |
#4 | $0.3M | 6 | N/A | N/A |
#5 | $0.2M | 6 | N/A | N/A |